Physiomics Plc (PYC.L)
Builds software that predicts how tumors respond to cancer drugs
0.47-0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+2.2%
The outlook
Physiomics trades at 0.47p, positioned 40% of the way through its 52-week range. The stock shows mixed positioning relative to its moving averages, reflecting sideways momentum. Analyst coverage appears thin, and the overall sentiment leans neutral based on current market data.
What’s behind the score
Price trendMixed vs its moving averages
52-week range40% of the way from its 52-week low to high
Market cap
$2.1M
52-wk high
0.80
52-wk low
0.25
50-day avg
0.54
200-day avg
0.45
Trailing P/E
—